𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivastigmine for Dementia Associated with Parkinson's Disease

✍ Scribed by Emre, Murat; Aarsland, Dag; Albanese, Alberto; Byrne, E. Jane; Deuschl, Günther; De Deyn, Peter P.; Durif, Franck; Kulisevsky, Jaime; van Laar, Teus; Lees, Andrew; Poewe, Werner; Robillard, Alain; Rosa, Mario M.; Wolters, Erik; Quarg, Peter; Tekin, Sibel; Lane, Roger

Book ID
118741672
Publisher
Massachusetts Medical Society
Year
2004
Tongue
English
Weight
127 KB
Volume
351
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivastigmine versus placebo in hyperhomo
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients
✍ Paolo Barone; David J. Burn; Teus van Laar; Chuanchieh Hsu; Werner Poewe; Roger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract The effects of rivastigmine versus placebo in Parkinson's disease dementia (PDD) patients with elevated or normal/low plasma homocysteine were determined. In this prospective analysis of a 24‐week, randomly assigned, placebo‐controlled study of rivastigmine in PDD, subpopulations compri

Effects of rivastigmine in patients with
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub